All posts by imreal

Business: Executives

TRC Services of Texas, Inc. Today Announced that Jonathan Dimock has Joined the TRC Texas Team

Leave a comment


TRC Services, sucker rods, steel sucker rods, fiberglass sucker rods, artifcial lift

Jonathan Dimock


MIDLAND, Texas (PRWEB)

“We are excited to welcome Jonathan to our team,” said Ralph Stark, President of TRC Service of Texas, Inc. “Jonathan’s long history in the beam pumping market and his dedication to solving customer problems is very exciting. Jonathan wakes up every morning being his customers’ advocate, and we like that.”

Prior to joining TRC Services of Texas, Inc., Mr. Dimock was employed by Weatherford International as US Technical Sales Manager for two years. Before Weatherford, Mr. Dimock was employed by Rod Lift Consulting as Sales Manager for the Permian Basin for seven years. Mr. Dimock has held various positions at Norris, a Dover Company, CDI, and Dresser Oil Tools.

Mr. Dimock’s appointment is effective August 31, 2019.

About TRC Services, Inc.

Founded in 1996, TRC Services, Inc. is a leader in the sucker rod industry. TRC is uniquely positioned to manage its customers entire sucker rod programs. Product and service lines include new and remanufactured steel sucker rods, new Fiberflex Fiberglass sucker rods, sucker rod string designs, failure analysis, and well optimization services. TRC services customers throughout the United States through three plants in Midland, TX, and plant in Oklahoma City, OK.

For more information, please contact Ralph Stark at rstark(at)trcsuckerrods(dot)com.

Share article on social media or email:



Source link

Legal / Law: Criminal Law

Established Carmel Divorce & Family Law Firm, Hollingsworth & Zivitz, PC Announces Merger with Carmel Firm, Roberts Means, LLC to Form Hollingsworth Roberts Means, LLC

Leave a comment


Hollingsworth Roberts Means, LLC

Together, we will challenge ourselves and our unified team to raise our standards of client service and efficiency even higher.


CARMEL, Ind. (PRWEB)

Kena Hollingsworth of Hollingsworth & Zivitz, PC (“HZ”), together with Jeffrey D. Roberts and William P. Means of Roberts Means, LLC (“RM”) proudly announce the merger of the two Carmel-based law firms to form the full-service litigation and family law firm, HOLLINGSWORTH ROBERTS MEANS, LLC (“HRM”).

Earlier this summer, HZ announced that co-founder Hollingsworth had reached an agreement to purchase sole ownership of the divorce & family law firm she opened 15 years ago. Blessed with numerous options, and after careful contemplation of the next chapter for herself and her loyal HZ colleagues, the ultimate decision to merge with RM was an easy one for Hollingsworth.    

“I believe that HZ established an excellent reputation in our community by prioritizing our clients’ emotional needs along with their need for financial and legal counsel. Our primary mission has always been to guide each client into the next best stage of life with integrity and with the least amount of emotional turmoil as possible. I believe RM has demonstrated the same care for and commitment to its clients—just with a broader litigation focus.”

Hollingsworth’s professional counterparts and longtime friends at RM similarly built their firm’s reputation by prioritizing exceptional client service—not only in the family law arena but also as a full-service litigation boutique serving local and national businesses. According to Roberts, “RM prides itself on offering clients a superior level of attention and cost management via operational processes that veer from the traditional law firm norms.”

“The breadth and depth of the experience that Jeff and Bill bring to the table provide invaluable resources to clients involved in disputes ranging from traditional divorce and family law matters to complex business disputes,” Hollingsworth said. “But even more so, RM’s positive culture, its attorneys’ ability to effectively communicate and relate to clients, and the firm’s focus on providing real value to clients, were selling points that were impossible to ignore.” Per Means, “Together, we will challenge ourselves and our unified team to raise our standards of client service and efficiency even higher.”

All three law graduates of Indiana University, HRM’s founders share a core goal to grow a client-focused business, but they respect and appreciate that each brings something unique as well. Hollingsworth’s personal experience as a child of divorce provides her with an extraordinary ability to empathize with clients and clients’ children alike. Accordingly, she approaches legal issues with a commitment to minimizing conflict and creating long term solutions to set families up to positively co-parent (or just co-exist) after a divorce. Means draws upon his background in the mental health field to bring a compassionate perspective and a unique ability to understand and communicate, while his extensive litigation experience provides clients with unwavering confidence. Roberts has an impressive business background, earning a double major in finance and marketing from IU’s Kelley School of Business and having worked as a financial analyst for an investment bank before law school. His experience, coupled with an innate ability to bring business principles and plain language to guide clients toward solutions to complex matters, adds a valued perspective to the HRM team.

Accompanying Hollingsworth from the legacy HZ firm are attorneys Genevieve Keegan Bedano, Anne-Marie Briscoe, Kristy Horvath, and Ashley Roncevic, along with business manager, Hillary Showley. Joining from the RM team, along with Roberts and Means, are attorneys Kimberly McCabe, Angela Hamm, and Jamie Meyer. For the next several months, the combined HRM firm will continue working out of two locations – HZ’s office located at 11555 N Meridian Street, Suite 530, Carmel, IN 46032; and RM’s office at 12805 E. New Market Street, Suite 300, Carmel, IN 46032. Later this year, the HRM team will join together in their new HRM office building currently under construction in the center of Carmel’s fast-growing Village of West Clay. The team is excited to transition to the new building with modern amenities in a uniquely quaint setting.

Like its future new home, the firm’s new website, http://www.HRMlaw.com, while functional and informational, is also very much under construction. In the meantime, any members of the HRM team can still be reached by calling 317-569-2200, 317-353-3600 and 317-DIVORCE or by emailing any of the firms’ attorneys at their HZ or RM email addresses or new addresses which can be found on the firm’s website.

Share article on social media or email:



Source link

Science: Biology

Bristol-Myers Squibb, Boehringer Ingelheim and Others to Present Use of Carterra’s Next Generation Antibody Screening Technology at Symposia Across the US and Europe

Leave a comment


News Image

Our upcoming symposia series will provide attendees with real-world examples of the LSA applications in drug discovery.


SALT LAKE CITY (PRWEB)

Carterra® Inc., the world leader in high-throughput antibody screening and characterization, will host a series of symposia across the United States and Europe entitled, The therapeutic antibody revolution in the post genomics era. Leading industry experts from some of the most influential pharmaceutical, biotech companies, and institutions in the world such as Bristol Myers Squibb, Boehringer Ingelheim, and the Huntsman Cancer Institute will provide insight on using high throughput surface plasmon resonance (SPR) technology to explore the full kinetic and epitope diversity of antibody libraries.

The symposia will take place in Cambridge, MA (September 10, 2019), San Diego, CA (September 17, 2019), San Francisco (September 19, 2019) and Munich, Germany (October 8, 2019). Presentations from leading industry experts and Carterra will demonstrate how high throughput SPR using the Carterra LSA™ is facilitating a paradigm shift in antibody screening, enabling higher information content assays to be conducted earlier in the research pipeline. This essentially combines screening and detailed characterization in the same step to increase efficiency and productivity and to reduce expenditure during drug discovery and development. For detailed schedules and registration information for each event please see the Carterra website.

Christopher Silva, Vice President of Marketing at Carterra commented: “Our upcoming symposia series will provide attendees with real-world examples of the LSA applications in drug discovery. Following our recent expansion into Europe with the opening of a new Customer Experience Center in Munich, Carterra customers are excited to spread the word about our revolutionary platform to even more scientists across the US and in Europe.”

Recent updates to the Carterra website highlight the therapeutic areas where high throughput SPR is making a difference from cancer (immuno-oncology) and heart disease to infectious diseases/vaccines, autoimmune diseases, and pain. The impact of the Carterra LSA on different antibody formats including discovery platforms, bispecifics, antibody-drug conjugates (ADCs), and CAR-T therapy is also explained in detail.

Dr Yasmina Abdiche, PhD, Chief Scientific Officer at Carterra elaborated: “The Carterra LSA is a high throughput SPR platform that is disrupting antibody analytics. The LSA can measure the binding kinetics and affinities of hundreds of interactions in parallel and perform comprehensive epitope binning experiments on up to 384 antibodies per chip. With the additional advantages of minimal sample consumption and industry-leading analysis software, the LSA is streamlining the library-to-leads triage by saving time, cost, and resources in discovering clinically-ready molecules for a number of diseases and conditions.”

About Carterra, Inc.

Carterra® is the leading provider of high throughput technologies designed to accelerate and improve the discovery of novel therapeutic candidates. Carterra’s LSA™ instrument, software, and consumables for monoclonal antibody (mAb) characterization deliver up to 100 times the throughput of existing platforms in 10% of the time while using only 1% of the sample required by other systems. The LSA combines patented microfluidics technology with real-time high throughput Surface Plasmon Resonance (HT-SPR) and industry-leading data analysis and visualization software to revolutionize mAb screening. Carterra, Inc. is based in Salt Lake City Utah, and has Customer Experience Centers in Dublin, California, Newtown, Pennsylvania, and Munich, Germany. For additional information, please visit https://carterra-bio.com/.

Share article on social media or email:



Source link

Society: Christianity

Gary Fuss and Xulon Press Share Amazing Stories that Show God is Real

Leave a comment


News Image

Many will grow in the love, mercy, and grace in authentic discipleship for the Lamb of God in the power of The Holy Spirit


KEYSTONE HEIGHTS, Fla. (PRWEB)

Minister Gary Fuss shares accounts of miracles, dreams and angelic encounters in his newest book, POP ($23.99, hardback, 9781545669990, $14.99, paperback, 9781545669983; $7.99, e-book, 9781545670002).

“Many will grow in the love, mercy, and grace in authentic discipleship for the Lamb of God in the power of The Holy Spirit,” said Fuss.

Gary Fuss is a Graduate of Grove City College, Pa. and received his M.Div. from Pittsburgh Theological Seminary. Fuss pastored 35 years in West Virginia, Pennsylvania, and Florida, preached Revivals and founded the Ephesians 4 Prayer Fellowship.

Xulon Press, a division of Salem Media Group, is the world’s largest Christian self-publisher, with more than 12,000 titles published to date. POP is available online through xulonpress.com/bookstore, amazon.com, and barnesandnoble.com.

Share article on social media or email:



Source link

Technology: Computer

Noblis Autonomous Vehicle Interoperability Concept Receives 2019 Government – Industry Innovator Award

Leave a comment


The Noblis Po8 approach can have a significant impact on public sector endeavors, unmanned systems and the future of human-machine interaction.


RESTON, Va. (PRWEB)

Noblis, a leading provider of science, technology and strategy services to the federal government has received a 2019 Government – Industry Innovator award from 1105 Public Sector Media Group for Pieces of Eight (Po8), a trusted autonomous operations system that enables ad hoc collections of autonomous machines to communicate, self-organize, and plan coordinated motions and actions based on trust earned in prior interactions. Noblis will be recognized at the Government Innovation Awards event on Nov. 7. The awards celebrate the transformative public-sector activities from government, industry and individuals that are reimagining public-sector IT, according to 1105 Media.

“We are delighted to be recognized as a leader and innovator in the autonomy at scale arena, one of the many research efforts Noblis has undertaken in the past ten years to study the effects of autonomy on a larger scale – across air, sea, land, space and cyber domains,” said Amr ElSawy, Noblis president and chief executive officer. “Innovation is a common thread at Noblis and programs such as Po8 demonstrate how our forward-thinking research and technical solutions are helping our government customers solve their most complex challenges.”

The Noblis Po8 trusted autonomous operations concept has received significant recognition since its public release, including winning the Highest Potential Impact Award and the Most Creative Award at the MOBI (mobility open blockchain initiative) Grand Challenge in Munich, Germany in February 2019. More info here.

MOBI is a nonprofit global foundation formed to accelerate the adoption of standards in blockchain, distributed ledgers, and related technologies for the benefit of consumers, communities and mobility industries.

“The Noblis Po8 approach can have a significant impact on public sector endeavors, unmanned systems and the future of human-machine interaction,” said Mile Corrigan, vice president Federal Civilian Solutions, Noblis. “Our system enables nearby connected machines – such as autonomous passenger vehicles, autonomous drones or autonomous robots traversing hostile terrain – to share situational awareness regarding obstacles and threats projected over time, and collectively plan actions that avoid collision or other conflicts.”

The Noblis Po8 process links heterogenous autonomous machines using ad hoc networking and blockchain technology to demonstrate the effects of orchestrated autonomy in comparison to isolated autonomy. The Po8 system includes an accountability process of trust scores which are recorded on blockchain technology to help ensure transparency, accuracy and the security of the system.

“Po8 allows pick-up teams of autonomous machines to perform as if they have trained together extensively,” said Karl Wunderlich, Noblis research team lead. “Further, if one machine in the system malfunctions or begins to perform erratically, the team will self-organize to re-assign critical team functions and isolate the compromised machine.”

ABOUT NOBLIS

Noblis is a dynamic science, technology, and strategy organization dedicated to creating forward-thinking technical and advisory solutions in the public interest. We bring the best of scientific thought, management, and engineering expertise together in an environment of independence and objectivity to deliver enduring impact on federal missions. Noblis works with a wide range of government clients in the defense, intelligence and federal civil sectors. Together with our wholly owned subsidiary, Noblis ESI, we tackle the nation’s toughest problems and support our clients’ most critical missions.

Share article on social media or email:



Source link

Health

LifeCare Announces New Mobile App For Its Industry Leading Backup Care Service

Leave a comment


LifeCare

LifeCare

As demand for our backup care services continue to escalate, we thought it important to offer our members even greater flexibility to manage it all through this best-in-class app.


SHELTON, Conn. (PRWEB)

The country’s leading work-life provider, LifeCare, is pleased to announce the launch of its new Backup Care Connection mobile app, supporting their premier backup care assistance service known for helping employees minimize disruption when their regular care arrangements fall through. With the app’s release, LifeCare is making it more convenient for members to manage all aspects of their backup care needs, whenever and wherever they are.

“As demand for our backup care services continue to escalate, we thought it important to offer our members even greater flexibility to manage it all through this best-in-class app,” says Peter Burki, CEO of LifeCare, “Now members can engage with us through any method they prefer — phone, web or app — to receive the right backup care solution they need.”

The app allows members to manage all aspects of their Backup Care benefit, including the ability to request care for their covered dependents such as children, seniors, pets and even themselves. Additional features include ability for employees to track their backup care utilization, view available visits, update or modify upcoming care reservations, submit for reimbursement and more.

According to Apperian, 91% of corporate employees are using at least one mobile app. Employees expect that the services they need be available as an app on their mobile devices, available at their fingertips. With the new Backup Care Connection mobile app, reliable backup care is just a few taps away.

Employers that offer Backup Care Connection to their employees recognize the value of the service, both in helping to alleviate the caregiving burden faced by their workforce and helping to reduce employee absenteeism. With the robust and flexible solution offered by LifeCare, children, aging loved ones, pets and even employees who are recovering from serious illness or surgery are covered.

As Burki referenced, LifeCare’s backup care services have seen steady growth in both demand and usage as more and more corporations look to provide valuable, productivity-enhancing care support for their employees. These nationwide companies specifically choose LifeCare’s Backup Care Connection because it’s the most flexible in the industry, enabling members to choose from a large selection of network care providers, locations, and out-of-network options (including their own preferred privately secured caregiver such as a personal babysitter, friend or even family member). Plus, members can schedule care up to 30 days in advance or even at the last minute. As a result, Backup Care Connection offers unmatched efficiency in reducing employee stress while increasing their work attendance and productivity.

Beyond Backup Care Connection — as the country’s leading work-life provider — LifeCare assists its members in the areas of parenting, senior care, legal guidance, financial help, home services and wellness. Specifically, LifeCare’s specialists provide personalized guidance 24/7/365 and connect employees with the solutions they need, when and where they need them.

About LifeCare

LifeCare provides employer-sponsored work-life benefits to 61,000 clients, including Fortune 500 companies and large branches of the federal government, representing 100 million members nationwide. In addition to child and backup care solutions, LifeCare also provides a full suite of work-life solutions that save members time with personal life needs such as Senior Care Management, Homework Connection, Mothers@Work, MilkShip, LeaveCoach and BenConnect. LifeCare also operates LifeMart, an online discount shopping website that provides real savings on everyday products and needs. LifeCare is headquartered in Shelton, CT.

Share article on social media or email:



Source link

Health

Study shows Mesenchymal Stromal Cells importance of tissue origin in predicting function

Leave a comment



DURHAM, N.C. (PRWEB)

A new study released today in STEM CELLS demonstrates that mesenchymal stromal cells (MSCs) expanded from adipose tissue (ASC) outperform those expanded from bone marrow (BM-MSCs). Importantly, while several previous studies have compared the performance of BM-MSCs versus ASCs, this is the first to pair MSCs from the same donor to show that tissue, rather than donor origin, is the functional predictor.

“Numerous clinical trials are evaluating the therapeutic potential of MSCs in degenerative and inflammatory diseases,” said lead investigator Karin Tarte, Pharm D, Ph.D., of the Université de Rennes. “However, the influence of their tissue of origin on their functional properties, including their immunosuppressive activity, remains unsolved.

“Prior to our study, the comparison of ASCs versus BM-MSCs was essentially completed using MSC batches obtained from different donors. We demonstrated for the first time on a large series of ASCs and BM-MSCs, obtained from the same donors, the strong impact of tissue origin on these cells’ properties. Moreover,” she added, “we pinpointed that ASCs could be an interesting alternative to BM-MSCs for therapeutic applications, considering their huge expression of anti-inflammatory and immunosuppressive molecules.”

To conduct their study, the investigators produced paired BM-MSC and ASC batches from 14 healthy donors, cultured under identical clinical grade-like conditions. They then compared them using transcriptomic (that is, all RNA molecules in a cell or a population of cells), phenotype (their physical characteristics) and functional analyses. Lastly, they validated the results on purified native MSCs to infer which differences were really endowed by tissue of origin.

What they learned was that the cultured MSCs segregated together by tissue origin rather than donor origin, which translated into distinct immune-related gene signatures, phenotypes and functional cell interactions.

“In particular, ASCs exhibited an immune profile consistent with a stronger inhibition of T-cell and myeloid cell immune response and a lower immunogenicity,” Dr. Tarte said. “This study supports the need to select therapeutic MSCs by tissue of origin functionality,” she concluded.

“The ability to assess key characteristics of adipose and bone marrow-derived mesenchymal stem/stromal cells from the same individual has not before been done on such a defined and large-scale manner,” said Dr. Jan Nolta, Editor-in-Chief of STEM CELLS. “The report from Tarte et al gives us an important comparison from which we can draw key insight for future clinical trials”.

The full article, “Integrated transcriptomic, phenotypic, and functional study reveals tissue-specific immune properties of mesenchymal stromal cells,” can be accessed at https://stemcellsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/stem.3077.

About the Journal: STEM CELLS, a peer reviewed journal published monthly, provides a forum for prompt publication of original investigative papers and concise reviews. The journal covers all aspects of stem cells: embryonic stem cells/induced pluripotent stem cells; tissue-specific stem cells; cancer stem cells; the stem cell niche; stem cell epigenetics, genomics and proteomics; and translational and clinical research. STEM CELLS is co-published by AlphaMed Press and Wiley.

About AlphaMed Press: Established in 1983, AlphaMed Press with offices in Durham, NC, San Francisco, CA, and Belfast, Northern Ireland, publishes three internationally renowned peer-reviewed journals with globally recognized editorial boards dedicated to advancing knowledge and education in their focused disciplines. STEM CELLS® (http://www.StemCells.com) is the world’s first journal devoted to this fast paced field of research. THE ONCOLOGIST® (http://www.TheOncologist.com) is devoted to community and hospital-based oncologists and physicians entrusted with cancer patient care. STEM CELLS TRANSLATIONAL MEDICINE® (http://www.StemCellsTM.com) is dedicated to significantly advancing the clinical utilization of stem cell molecular and cellular biology. By bridging stem cell research and clinical trials, SCTM will help move applications of these critical investigations closer to accepted best practices.

About Wiley: Wiley, a global company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical and scholarly journals, combined with our digital learning, assessment and certification solutions, help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 200 years, we have delivered consistent performance to our stakeholders. The company’s website can be accessed at http://www.wiley.com.

Share article on social media or email:



Source link

Health

LensDirect.com Named to 2019 Inc. 5000 List for Third Year in a Row

Leave a comment


https://www.prweb.com/

LensDirect.com – One of The Most Successful Companies in America

“We’re excited to once again be honored by Inc. Magazine as one of America’s fastest-growing private companies,” – Ryan Alovis, CEO of LensDirect.com


GARDEN CITY, N.Y. (PRWEB)

Inc. Magazine has announced that LensDirect.com, one of North America’s largest independent retailer of optical goods has been ranked in 1101th place on the annual Inc. 5000, the most prestigious ranking of the nation’s fastest growing private companies.

The list represents the most successful companies within the American economy’s most dynamic segment – independent small businesses.

Many well-known companies first gained national exposure as honorees on the Inc. 5000. Companies like Microsoft, Dell, Domino’s Pizza, LinkedIn, Zillow, Yelp, Pandora, and many others.

“We’re excited to once again be honored by Inc. Magazine as one of America’s fastest-growing private companies,” said Ryan Alovis, CEO of LensDirect.com. “With over 70% of North American adults having corrective vision needs, yet the eyecare industry is plagued by inconvenience, high costs, and subpar customer care – LensDirect.com is uniquely positioned to become America’s Optical Store.”

LensDirect.com expects its growth numbers to continue to rise as it puts more emphasis on enriching their customer relationships. Over the past few years, they’ve launched novel concepts such as their ‘set it and forget it’ AutoRefill Subscription and Dedicated Account Reps. Those endeavors have been key factors in its extraordinary customer satisfaction rating of 97%.

Additionally, LensDirect.com is dedicated to becoming a single-source full-service online optical store by expanding their product offerings with accessories, premium sunglasses, prescription eyewear and lens replacement.

“The companies on this year’s Inc. 5000 have followed so many different paths to success,” says Inc. editor in chief James Ledbetter. “There’s no single course you can follow or investment you can take that will guarantee this kind of spectacular growth. But what they have in common is persistence and seizing opportunities.”

Complete results of the Inc. 5000 can be found at http://www.inc.com/inc5000.

For more information on LensDirect.com, please visit the company’s website at http://www.lensdirect.com

About LensDirect.com

Founded in 1992, LensDirect.com is a New York-based online retailer of optical goods. Originally a contact lens mail order company, it has evolved into the leading provider of name-brand contact lenses, accessories, sunglasses, prescription eyewear and lens replacement on the internet.. With a customer first mentality, LensDirect.com has found its place as one of the highest-rated online retailers.

About Inc. 5000

The Inc. 5000 is a list of the fastest-growing private companies in the nation. Started in 1982, this prestigious list has become the hallmark of entrepreneurial success. The Inc. 5000 Conference & Awards Ceremony is an annual event that celebrates the remarkable achievements of these companies. The event also offers informative workshops, celebrated keynote speakers, and evening functions.

Share article on social media or email:



Source link

Health

Purdue Pharma Deal Leaves Opioid-Dependent Babies Out in the Cold

Leave a comment


A legal team continues to work with the Judge Polster towards establishing a designated settlement class for NAS children, said Ms. Brustowicz. “Negotiations are ongoing”, she added.


NEW ORLEANS (PRWEB)

On August 27, 2019 it was reported for the first time that Purdue and its lawyers met, on August 20, 2019, in Cleveland, Ohio before the MDL Judge, the Plaintiffs and the Attorney Generals representing some 10 States to offer upwards of $12 billion to settle to the nearly 2,000 lawsuits filed by municipalities and Native American tribes and these States.

What sounds like a positive step forward, following so close behind Oklahoma’s landmark verdict against Johnson & Johnson for its role in America’s current drug crisis is, in actuality, a bombshell to the team of attorneys, non-profit advocates and medical experts fighting for the more than 200,000 children born with Neonatal Abstinence Syndrome (NAS) because their mothers used prescription opioids while pregnant.

“We are deeply involved in complex litigation to create a medical monitoring trust fund for babies diagnosed with NAS,” said Celeste Brustowicz of the Opioid Justice Team. “Both these legal actions leave to chance any hope for these innocent victims because they take the easy way out and offer a blanket settlement in favor of government general funds.”

There are more than 35 state class actions on behalf of NAS children filed and awaiting a specific recognition in the opioid multi-district litigation currently before federal Judge Dan Polster. Those representing these children have for years explained why a settlement track replicating the infamous Big Tobacco settlement would not help these children.

Many legal experts have also weighed in, warning that many of the government entities which reached a record $206 billion settlement with the leading cigarette makers are using the settlement monies for general fund needs, ignoring pleas by health experts that substantial dollars must be spent on smoking cessation programs, especially those aimed at children.

Medical experts are in agreement that NAS babies will suffer from some combination of social, interactive, behavioral, cognitive and educational deficits, from the time of birth onwards; nonetheless, substantial intervention improves the quality of life and outcomes for child and caregiver alike, said health representative Brent Bell. The most immediate crisis arises from the fact that the most severe NAS symptoms occur while these babies are in Neo-Natal Intensive Care Units, including uncontrollable trembling and seizures, gastrointestinal complications, and sleep abnormalities.

“The Purdue Pharma settlement plan is an outrage because it fails in any way to address that crisis,” said Mr. Bell. “In fact, the medical maxim ‘dose makes the poison’ is a theory of awarding damages utilized by Purdue’s proposal which is why it is facile and appears egregiously and hopelessly flawed. Under Purdue’s current proposal these child victims of the opioid crisis get nothing.”

As reported, the plan calls for Purdue Pharma to declare Chapter 11 bankruptcy and emerge restructured as a for-profit public benefit trust. Purdue claims the value of the trust would include the provision of more than $4-billion in drugs to cities, counties and states (the ‘in-kind’ payment component), together with the profits to be derived from the sale of drugs, totaling an additional $7-8 billion (the ‘direct payment’ component).

“The fund is scheduled to expire after 10 years, allowing Purdue and the Sackler family, alike, to go on as if nothing had ever happened,” said Ms. Brustowicz.

“It sounds like a financial coup for governments that have borne substantial costs from the opioid epidemic, but it’s only a good deal if you forget about these NAS babies who wouldn’t get a dime under this plan,” said Greg Williams, the former director of Facing Addiction and an addiction recovery advocate.

A legal team continues to work with the Judge Polster towards establishing a designated settlement class for NAS children, said Ms. Brustowicz. “Negotiations are ongoing”, she added.

“Although we are confident that our babies will ultimately prevail and receive justice, they haven’t yet gained status as a negotiated settlement class, which is why the news of the separate deal for Purdue Pharma is so unsettling,” says Ms. Brustowicz.

Opioid Justice Team is a group of highly skilled attorneys who have engaged with doctors and civic leaders fighting to end our nation’s opioid epidemic by identifying real solutions to the crisis. What sets our team apart is our commitment to our clients not only to obtain compensation for their damages, but to advocate for a comprehensive settlement that will address the root causes of the opioid crisis and eliminate the systemic conditions that allow it to exist. We’re about justice, relief, and answers to the short and long-term challenges of America’s unprecedented prescription opioid addiction problem.

Share article on social media or email:



Source link

Health

Innovative Pathogenic DNA Analysis Technology to be Explored on Advancements Television Series.

Leave a comment


News Image

“Our software translates pathogenic DNA data from ATCG to symptoms, such as fever or pneumonia, so that doctors and patients can easily understand the health impacts of the pathogens.”


JUPITER, Fla. (PRWEB)

An upcoming episode of Advancements with Ted Danson scheduled to broadcast 1Q/2020 will educate about the latest developments in genome sequencing analysis. Check your local listings for more information.

Advancements will go behind-the-scenes to learn about the innovation taking place at Rivermap Research & Consulting and will explore its revolutionary pathogenic DNA analysis technology, which predicts in real-time, the possible health impacts from microorganisms, proteins or any manmade DNA strains.

“Our software translates pathogenic DNA data from ATCG to symptoms, such as fever or pneumonia, so that doctors and patients can easily understand the health impacts of the pathogens. The scientists who design DNA food/drugs can also use this software to confirm the functions and side-effects of their products at the design stage. Viewers will see how this little soldier is making great contributions in the healthcare industry,” said Mai Wang, CEO of Rivermap Research and Consulting.

Analyses results are generated in REAL TIME. The technology will also enable healthcare providers to use alternative medicine, such as local herbs, for treatment. Watch Advancements to learn more.

About Rivermap Research & Consulting:

Rivermap translates pathogenic DNA data to symptoms which allows doctors and patients to directly understand the health impacts of pathogens. It also enables using alternative medicine to treat infectious diseases at lower cost. The same technology can be used by scientists as a safety test tool for their synthetic DNA products at design stage, reducing a large portion of the R&D cost. For more information, visit: http://www.rivermapsolution.com.

About Advancements and DMG Productions:

The Advancements series is an information-based educational show targeting recent advances across a number of industries and economies. Featuring state-of-the-art solutions and important issues facing today’s consumers and business professionals, Advancements focuses on cutting-edge developments, and brings this information to the public with the vision to enlighten about how technology and innovation continue to transform our world.

Backed by experts in various fields, DMG Productions is dedicated to education and advancement, and to consistently producing commercial-free, educational programming on which both viewers and networks depend.

For more information, please visit http://www.AdvancementsTV.com or call Richard Lubin at 866-496-4065.

Share article on social media or email:



Source link